Epilepsy Today Latest News
Epilepsy Action has launched a new survey, aiming to find the extent of the impact of the cost-of-living crisis on people with epilepsy.
Update on 9 August 2022
This medicine is back in stock and available for pharmacists to order.
People with epilepsy will be eligible for a booster COVID-19 vaccine in the autumn, the Department of Health and Social Care has said.
This is informed by recommendations from the Joint Committee on Vaccination and Immunisation (JCVI).
The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a safety review into the epilepsy medicine topiramate, announced on 21 July. The review comes after a study has reported an increased risk of problems with development to babies exposed to the medicine in the womb.
Age at epilepsy diagnosis and EEG can help predict returning seizures after stopping epilepsy medicines, study finds
Adolescent age at diagnosis and unusual EEG findings are among the factors that predict breakthrough seizures after withdrawal of epilepsy medicines in children, according to a new Epilepsy & Behavior study.
Update on 15 July 2022
We’ve had an update from Novartis that Trileptal and oxcarbazepine Sandoz are in stock in all strengths, but there’s limited stock of oxcarbazepine Sandoz 150mg tablets.
Epilepsy Action has said it is “alarmed at the worrying lack of progress” the government has made in the last two years, following the safety review published two years ago today by Baroness Cumberlege in 2020.
Desitin Pharma, who make Episenta (sodium valproate) prolonged release capsules and sachets, have contacted us to confirm these are in stock.